1. P.07.12 CLINICAL RESPONSE, EFFECTIVENESS, SAFETY AND MUCOSAL HEALING INDUCTION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A PRELIMINARY REAL-LIFE MULTICENTRIC EXPERIENCE IN SOUTHERN ITALY. Issue 2 (15th March 2018) Authors: Contaldo, A.; Losurdo, G.; Bossa, F.; Biscaglia, G.; Mazzuoli, S.; Fanigliulo, L.; Tursi, A.; Lovero, R.; Ierardi, E.; Principi, M.B.; Di Leo, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM "LONG VEDO" ITALIAN MULTICENTER STUDY. (March 2023) Authors: Mocci, G.; Maconi, G.; Cataletti, G.; Mantia, B.; Serio, M.; Scarcelli, A.; Onidi, F.M.; Pagnini, C.; Graziani, M.; Di Paolo, M.; Pranzo, G.; Luppino, I.; Paese, P.; Monterubbianesi, R.; Faggiani, R.; Ferronato, A.; Perini, B.; Savarino, E.; Binaghi, L.; Schiavoni, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗